chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within one minute of vaccination, patient was flushed, light-headed, dizzy, itching, and tingling down right side.  Also had mild muscle aches and a headache.  Had a similar reaction on her first dose.  Oxygen: 97% on room air, BP109/57 and HR 54.  Pt declined Benadryl and was taken to ED for further evaluation,
Pt had been mistakenly scheduled for Moderna COVID-19 vaccine 2nd dose, 4 weeks post 1st dose of Pfizer. Pt was administered dose of Moderna (0.5mL), and the error was discovered by the clinician after she went to complete his card. Records confirmed that he had received a 1st dose of Pfizer.  During the follow-up conversation about the error, did not appear to have recalled which vaccine he originally had received. Pt questions were addressed.
get the shingles shot / it gave it to them/ suspected vaccination failure; the shingles shot / it gave it to them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported for reporter's mother. The age at vaccination was not reported. The reporter said that he/she almost forgot, one of his/her best friends called and said they were going to go and the reporter's mother went to get the shingles shots and asked to the reporter if reporter was going to get one and reporter said no well guess what it gave shingles to them. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. The case was linked with case US2021AMR159199, reported by same reporter.
Pt recv vax on 10/20/98; on 10/25/98 pt exp erythematous rash on Rt leg & left ear, irritability & vesicular lesion on right & left buttock also face
Tired, sore joints, headache, dizzy, started period one week AFTER finishing my last cycle.
Informatino has been received from a medical assistant referring to a 9 week old male patient. No relevant medical history or concurrent conditions were reported. On 07-AUG-2015 the patient was vaccinated with improperly stored PEDVAXHIB (lot # K002935, expiration date 11-DEC-2016; dose and route not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
9 Hours after the shot, started feeling body exhaustion followed by a headache and decided to go to bed. 13.5 Hours after the shot, woke up and legs felt like pins and needles, very uncomfortable. Stayed in bed and couldn't fall asleep. 14 Hours post injection felt Severe abdominal and Chest Pain. Chest pain felt like a stabbing sensation. Passed out because of the pain. Woke up and asked husband what happened, husband said I was only out for 10 seconds and sounded as though I was trying to breathe. Had to immediately get out of bed because I felt nauseous and started vomiting. Sat on the floor for a few minutes vomiting until the nausea passed. Brushed teeth, drank water, and returned to bed. Once I was in bed, I was shaking/shivering nonstop for 20 minutes until I fell asleep. Husband was also shaking and shivering, we got our second dose at the same time. Woke up throughout the rest of the night and gradually felt better. 28 Hours post second dose only experienced mild headache and body fatigue.
Information has been received from a physician concerning a 9 year old Black male who on 01/06/99 was vaccinated with a 1st dose of Hepatitis B vaccine recombinant. Subsequently, the patient experienced spots and itching at the injection site over the entire arm. There was no reported pustules or drainage. The patient recovered approximately 2 weeks after onset of symptoms. The patient's mother brought him in for the second vaccination and the physician deferred the second shot. No further information is available.
Arthralgia chills, fatigue, arm soreness, sweats Narrative: Arthralgia, chills, fatigue, sweats, arm pain; taking tylenol.
Chest pain began 23 hours after injection, followed by arm numbness in left arm. This lasted for over 24 hours. Today, day 4 I am having itching, swelling and welting up my arm near injection site. I have had increased redness, pain and swelling since the 2nd injection was given.
Pinkeye, sore throat and dry cough.   Went to doctor on 10/4/22.
not feeling better; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had COVID-19 vaccine but was not feeling better. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Received imm 4/5/05. On 4/15/05 developed rash to face, neck, progressed to lower trunk by 4/18/05. Itchiness, denies fever (although had one episode of chills briefly yesterday). Denies pain or cough. Tx: Benadryl 100mg per itching, Claritin 60mg 1 tab for itching.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Mild arm pain), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE INDURATION (Harden Injection site), VACCINATION SITE WARMTH (Hot injection site) and VACCINATION SITE PRURITUS (Extremely itchy injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Mild arm pain). On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE INDURATION (Harden Injection site), VACCINATION SITE WARMTH (Hot injection site) and VACCINATION SITE PRURITUS (Extremely itchy injection site). At the time of the report, VACCINATION SITE PAIN (Mild arm pain), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE INDURATION (Harden Injection site), VACCINATION SITE WARMTH (Hot injection site) and VACCINATION SITE PRURITUS (Extremely itchy injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Patient received treatment including Claritin, Zyrtec, Advil for pain and iced as needed. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jan-2021 and was forwarded to Moderna on 24-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Mild arm pain), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE INDURATION (Harden Injection site), VACCINATION SITE WARMTH (Hot injection site) and VACCINATION SITE PRURITUS (Extremely itchy injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Mild arm pain). On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE INDURATION (Harden Injection site), VACCINATION SITE WARMTH (Hot injection site) and VACCINATION SITE PRURITUS (Extremely itchy injection site). At the time of the report, VACCINATION SITE PAIN (Mild arm pain), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE INDURATION (Harden Injection site), VACCINATION SITE WARMTH (Hot injection site) and VACCINATION SITE PRURITUS (Extremely itchy injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Patient received treatment including Claritin, Zyrtec, Advil for pain and iced as needed.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Chills-Mild
Patient received 1st Moderna dose at 9:11am and was alert, talking, and felt fine after dose and 15 min wait time. Patient proceeded to go shopping in the store. At 9:38am front end notified me that a girl I gave a vaccine to passed out in check out line and they already called 911. She was sitting in chair and talking to front end personnel when I reached patient and they had placed her in a chair. Patient said she was still feeling dizzy so I helped her lay prone on the floor so she didn't pass out and fall down again. Ambulance arrived and took patient to ER to be checked out.
Received booster 5 months after second vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received booster 5 months after second vaccine) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received booster 5 months after second vaccine). On 18-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received booster 5 months after second vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.
Hives (red, itchy welts) face, back, neck, shoulders continuing to present (12/11/2011, treated with OTC cortisone.
Patient received Moderna vaccine for first in series and Pfizer for second in series accidently.  Followed up with patient and reaction reported.
Fever, chills, body aches, nausea, dizziness, and headache.
This spontaneous report was received from a physician and from a support services director via company representatives and refers to a patient of an unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 29-OCT-2015, the patient was vaccinated with a dose of an improperly stored GARDASIL 9 (strength: 0.5 ml) lot # L014198 and expiration date: 05-SEP-2017 (dose, anatomical location and route of administration were not reported). No adverse effects were reported. The dose of the vaccine was exposed to different temperature excursions (date unspecified): lasting for 88, 320, 192, and 40 hours, with the lowest recorded temperature of 30, 29, 33, and 34 degrees Fahrenheit (-11.11, -1.66, 0.55, and 1.11) respectively; and lasting for 64 hours, with the highest recorded temperature of 48 degrees Fahrenheit (8.88 degrees Celsius). The vaccine was stored in a refrigerator. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Received moderna vaccine on 3/11/21 and 4/8/21. Presented to ER on 12/21/21. Not to be found with COVID. Presented to ed for a left heel wound found to have cellulitis and abscess of left heel and AKI. Found to have COVID on 1/11/22 of admission. Patient was asymptomatic. Finally discharged on 1/22/22 as they were awaiting SNF placement.
Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023; No adverse event; She had expired vaccine that was administered on 15-Mar-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on 15-Mar-2023), PRODUCT STORAGE ERROR (Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023) and NO ADVERSE EVENT (No adverse event) in an 18-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 060B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on 15-Mar-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on 15-Mar-2023), PRODUCT STORAGE ERROR (Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (She had expired vaccine that was administered on 15-Mar-2023) and PRODUCT STORAGE ERROR (Vaccine expired on 26-Feb-2023, moved to refrigerator on 14-Mar-2023 and administered on 15-Mar-2023).    It was unknown if the patient was ever been diagnosed with or tested positive for COVID-19.  Concomitant medications of the patient were not reported.  The vial was initially stored in the refrigerator on 14-Mar-2023. The vial did not undergo any temperature excursions.  HCP stated that expired Moderna COVID-19 monovalent vaccine was administered to approximately 75-125 patients on 15-Mar-2023. There was potentially a second lot number that was expired and was administered to patients on 03-Mar-2023, but HCP did not have any details on this event at the time of reporting.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-716065 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716065:Master case
Cold like symptoms; had close interaction or exposure with the positive COVID-19 coworker; This is a spontaneous report from a contactable consumer. A 33-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL3302), via an unspecified route of administration on 12Jan2021 reported at about 18:30 at SINGLE DOSE at left arm for COVID-19 immunization. The patient's Medical history was reported as none.  The patient's concomitant medications were not reported. This Dental Hygienist is the patient who was administered her first dose of Pfizer COVID-19 Vaccine on 12Jan2021. She felt fine before being administered that dose. When she woke up 14Jan2021, she felt cold like symptoms. She just found out today: 15Jan2021 that her coworker who previously had a negative Rapid COVID-19 test result is actually positive for COVID-19 as of today: 15Jan2021. Caller reported the last time she herself had close interaction or exposure with the positive COVID-19 coworker was last night: 14Jan2021. Caller is in the line at this time to go get tested for COVID-19; but she wanted to ask if she should still get tested for COVID-19 or still get the second dose of the Pfizer COVID-19 Vaccine. She does not know when the second dose will be scheduled; she is still waiting on the email to tell her when she is supposed to go get the second dose. She does not know if she will or will not get the second dose related to these events yet. The outcome of the event Cold like symptoms was not recovered while unknown for the event exposure.
lower lip selling onset 2 days after second Moderna COVID vaccine, treated for possible delayed allergic reaction with bendadryl  50mg, claritin, Pepcid 20mg.   lip more swollen the next day and Prednisone 50mg given.   Pt. describes history of upper lip swelling sometimes after dental cleaning.   Lip worse, and sent to ER, found to have posterior lip abcess which spontaneously drained purulence,  Pt. admitted to Hospital for 3 days with improvement, discharged on Clindamycin and follow up with ENT.  Pt. also advised to see allergist with symptoms and if connected with history upper lip swelling post dental cleanings.
Upon internal review following has been added to the case on 10 Sep 2014: The patient required ER/Doctor visit. Initial report received from a healthcare professional on 25 June 2014. A 76-year-old male patient, whose medical history and concomitant medications were not reported, had received a dose of FLUZONE High Dose (batch number: U4494AA, expiry: 02 April 2013, dose, dose number, route of vaccination were not reported) in the left deltoid on 26 October 2012. On an unknown date after vaccination, the patient experienced itching and developed brachial plexopathy in right arm following flu vaccination. Patient was unable to use his right arm from shoulder to wrist. It was reported that patient required ER/ doctor visit. The patient was hospitalized following vaccination on an unspecified date. As a corrective procedure, laminectomy was performed in 2013. Lab investigation details were not reported. The outcome of the event was unknown. Documents held by sender: none. Addendum: 10 September 2014 Upon second medical examination of case at time of internal review the following has been modified in this case. The field of "For Vaccine Only: Required ER/Doctor Visit was marked as Yes". Missing patient information (street address and phone number) was added. The information about ER/ Doctor visit was added in the narrative. Follow-up information was received from a healthcare professional on 17 October 2014. Reporter's relationship to patient was provided as vaccine provider. County in which patient was vaccinated. According to the reporter, they had no additional information to provide.
High Fever; every bone ached; headache; rash on my neck; Dose Number: 3; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date Nov2021 (Lot number: FF2593) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Breast cancer" (unspecified if ongoing); "Allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: FLU taken for immunisation, administration date Nov2021; LETROZOLE; LEXAPRO; AMLODIPINE BESYLATE. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6203, Location of injection: Arm Right), administration date: Mar2021, when the patient was 42 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EP7534, Location of injection: Arm Right), administration date: Mar2021, when the patient was 42 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset Nov2021, outcome "unknown", described as "Dose Number: 3"; PYREXIA (non-serious) with onset 05Nov2021, outcome "recovering", described as "High Fever"; BONE PAIN (non-serious) with onset 05Nov2021, outcome "recovering", described as "every bone ached"; HEADACHE (non-serious) with onset 05Nov2021, outcome "recovering", described as "headache"; RASH (non-serious) with onset 05Nov2021, outcome "recovering", described as "rash on my neck". Therapeutic measures were not taken as a result of pyrexia, bone pain, headache, rash.  Additional information: Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient was not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Pt stated her arm at injection site became red and hot to touch 24 hours after receiving the vaccine.  She felt that she was running a fever but did not have a thermometer to verify.  Her arm developed a red rash with blister like bumps and became swollen,  She took Ibuprofen to elevate the pain and fever.  She presented to pharmacy 7 days after receiving the vaccination and her arm was still red but the swelling and bumps had subsided.
After the shot I had pain for a few days.  About a few weeks later I had pain in my upper arm and went to the doctor.  The doctor advised to get a X-ray and MRI for my pain.  The test showed inflammation in my arm.  I still had a bad pain and they decided to a IV injection.  I also did therapy for my arm.  I am still doing therapy and I still have pain in my arm.  When I move my whole joint in my arm hurts.   I am not able to work because the pain is so bad.
Two days after receiving booster dose, patient reported feeling chills and fever on Sunday 2/6/22 at 3 AM. Patient returned to facility on Monday 2/7/22 to report side effects. In addition, clinician noted the site where injection was administered (left arm) showed a large area of redness as well as being hot to the touch.
Acute hypoxic respiratory failure secondary to COVID-19 pneumonia Left pneumothorax 2/2 COVID-19, s/p chest tube insertion Covid-19 pneumonia with superimposed Hospital acquired bacterial pneumonia Sepsis with septic shock and multiorgan failure requiring pressors 2/2 above Acute kidney injury with anuria secondary to above Hypertension Hyperlipidemia Coronary artery disease Aortic valve replacement Congestive heart failure with diastolic dysfunction Chronic back pain Rheumatoid arthritis Anemia Hypothyroidism Diabetes mellitus II 71 yo Male with a history of hypertension, hyperlipidemia, coronary artery disease, aortic valve replacement, congestive heart failure with diastolic dysfunction, prostate enlargement, rheumatoid arthritis, and anemia presenting for cough, mild shortness of breath, and back pain. He reports that he is vaccinated and got both Moderna vaccines several months ago. He reports about 2 days of worsening fatigue, back pain, cough, and mild shortness of breath. He came to the ED for the cough and was found to have borderline low O2. He reports mild chest pain with cough only. No fever, chills, nausea, vomiting, bowel changes. His son also has COVID as is currently admitted.  Patient was vaccinated and inflammatory markers were elevated Overnight 8/11, his O2 worsened to 15L NC, however, he was able to be weaned back to 3L NC. He again worsened 8/14 with concerns for HAP vs aspiration PNA. He was started on empiric coverage but he continued to decompensate and it was decided to undergo RSI on 8/16. He was moved to the ICU and began to improve being able to tolerate wean down to 50% fiO2 but then on 8/19 he began to desaturate again. Stat XR noted L sided pneumothroax requiring chest tube insertion. Despite aggressive therapy he continued to decline going into renal and eventually multiorgan failure. Spouse was updated regularly during his admission of his progress and prognosis. On 8/23/21 family notified us to discontinue aggressive care, discontinue life support, and focus on comfort measures. Emergency services was called to the bedside as patient was found unresponsive. The patient was found to be in asystole. At 1223 the patient was pronounced deceased. Family was notified.